Protection from diet-induced obesity is however also observed in some experiments studying mice that lack the GLP-1 receptor [805,806], and further, in mice with concomitant deletion of both incretin receptors (DIRKO) [805]; these findings complicate considerations of the pharmacological potential of GIPR signal modification. This evidence concerns the gene GLP1R and obesity disorder.